Pallas Health Review 2026: Is It Legit? Pricing, Pharmacies, and Terms

Affiliate disclosure: Care Path Compare may receive compensation if you use a Pallas Health link and make a qualifying purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Is Pallas Health legit?

Pallas Health identifies Brentmoor, Inc. as the technology-platform operator. Its clinical disclosure states that medical care is provided through Lion MD, whose clinicians are licensed in the state where the patient is located and retain independent prescribing authority.

Pallas also publishes named medical leadership and identifies six pharmacy partners. Its current site explains which jurisdictions require a live video visit before prescribing and says it serves patients in all 50 states and Washington, D.C.

Those are useful legitimacy and transparency signals. They are not the same as proving that every patient will qualify, that every listed medication will be available in every state, or that every consumer will have the same experience.

Our current assessment: Pallas is a legitimate telehealth provider to research and compare. The most important consumer questions are the exact amount charged for the selected plan, the billing period, the actual dispensing pharmacy, the cancellation point, and how the six-month satisfaction policy applies to the selected plan.

Pallas Health at a glance

Commercial information was rechecked September 10, 2026 and may change.

How Pallas Health works

Pallas describes an online intake followed by review from a U.S.-licensed clinician. In states that permit asynchronous care when clinically appropriate, the clinician may review the submitted history without a real-time appointment. Pallas says a live video encounter is required before prescribing in Arkansas, Mississippi, New Mexico, North Dakota, Rhode Island, South Dakota, West Virginia, and Washington, D.C.

The clinician decides whether treatment is appropriate. Completing the intake does not guarantee a prescription.

If treatment is prescribed, Pallas routes the prescription to a partner pharmacy based on the medication, shipping state, and pharmacy capacity. Ongoing care can include messaging, follow-up review, and dose adjustments.

What does Pallas Health cost?

Pallas’s primary GLP-1 page currently emphasizes quarterly compounded plans:

• Compounded semaglutide: $597 every 12 weeks, described by Pallas as a $199/month average.
• Compounded tirzepatide: $897 every 12 weeks, described as a $299/month average.

The important number for cash-flow comparison is the actual 12-week charge, not only the monthly average. Twelve weeks is not three calendar months, and the $597 or $897 plan charge is what Pallas says is billed for that quarterly cycle.

Pallas also says longer plans can reduce the displayed monthly average and currently advertises semaglutide from $159/month on an annual plan. The primary page we reviewed did not publish the entire price ladder and total charge for every longer plan, so we would not calculate or assume those totals.

See our dedicated Pallas Health cost analysis for the billing details.

When does Pallas charge you?

This changed recently.

Pallas’s Terms, updated September 10, say that for plans purchased on or after September 8, 2026, checkout saves the payment method but does not charge it immediately. If a licensed clinician prescribes the selected plan, Pallas charges the plan price at that point and anchors future renewal to the prescription date.

If the clinician does not prescribe, Pallas says no charge is made. If the consumer cancels before the clinical decision, the current terms also say nothing is charged.

Older purchases may be governed by a legacy deposit system, so consumers who enrolled before September 8 should check the terms attached to their original order rather than assuming the new workflow applies.

Which pharmacies does Pallas Health use?

Pallas currently names six partner pharmacies:

• Belmar Pharmacy.
• Strive Pharmacy.
• Epiq Scripts.
• Casa Pharma Rx.
• The Pharmacy Hub.
• Foothills Pharmacy.

Pallas says the actual pharmacy depends on the medication, shipping state, and capacity. A useful pre-purchase question is therefore not merely “Does Pallas use licensed pharmacies?” but which pharmacy will dispense my prescription, and is it authorized to serve my state?

For compounded medication, also confirm the formulation, concentration, storage instructions, and shipment process provided for the actual prescription.

Does Pallas offer FDA-approved medications too?

Yes. Pallas currently advertises cash-pay access, when clinically appropriate, to FDA-approved brand-name products including Wegovy, Zepbound, Ozempic, and Mounjaro alongside its compounded options.

The distinction matters. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not generic versions of the brand-name drugs. They should not be described as FDA-approved substitutes or guaranteed equivalents.

Consumers comparing the two models should ask a licensed clinician about appropriate treatment options, then compare the actual cash price, pharmacy, coverage possibilities, and clinical rationale for the selected pathway.

Pallas Health’s six-month satisfaction promise

Pallas now publishes a six-month refund commitment for certain continuously active paid-plan users who meet the stated participation and claim requirements. The policy describes it as a commercial satisfaction commitment rather than a medical guarantee.

That distinction should be preserved. The existence of a refund policy does not guarantee weight loss or any other health outcome.

Before relying on the policy, read the current conditions and confirm:

• Which plan qualifies.
• What continuous participation means.
• Which check-ins or records must be completed.
• The exact claim window.
• Which payments would be included in a qualifying refund.
• Whether any prior refund affects eligibility.

Pallas Health reviews: what can consumers independently verify?

Pallas is a comparatively new consumer brand, so it does not yet have the long independent review history available for some larger telehealth companies. That makes operational transparency more important.

Instead of relying on a provider’s own testimonial average, consumers can independently check the operator identity, clinician information, state license, actual pharmacy, written policies, charge on their payment method, and shipment documentation.

A thin independent review footprint is not proof that a company is unreliable. It simply means there is less long-term consumer-experience evidence to weigh alongside the company’s own disclosures.

What we like about Pallas Health

• The company clearly identifies its platform operator and clinical network.
• It publishes named medical leadership and multiple partner pharmacies.
• It explains state-specific telehealth encounter requirements.
• New customers are not supposed to be charged until a clinician prescribes.
• Current compounded-plan pricing includes provider care and shipping rather than a separate membership fee.
• The site clearly distinguishes compounded medication from FDA-approved brand-name products.

What gives us pause

• The $199 and $299 figures are monthly averages derived from larger 12-week charges.
• The complete price ladder for every longer-term plan is not presented on the primary GLP-1 page.
• At least one Pallas state page contains language about membership and separately billed medication that does not cleanly match the main page’s bundled-price description.
• Public lab requirements and lab-cost responsibility are not fully standardized in the materials we reviewed.
• The six-month satisfaction promise has conditions and should not be read as a treatment-outcome guarantee.
• The brand is still relatively new, so independent long-term customer-experience evidence is limited.

Questions to ask before choosing Pallas Health

• What exact amount will be charged if the clinician prescribes my selected plan?
• Is my plan monthly, every 12 weeks, six months, or annual?
• What is the total plan-cycle charge, not just the displayed monthly average?
• When is my next renewal date?
• Which clinician will review my case, and are they licensed in my state?
• Will I need a live video visit in my jurisdiction?
• Which pharmacy will fill the prescription?
• Are any labs required, and are they included in the quoted price?
• When does the current cycle become non-refundable?
• What exact conditions apply to the six-month satisfaction policy?

Bottom line

Pallas Health has several strong transparency features for a newer telehealth provider: a named operator, a disclosed national clinical network, named pharmacies, current billing terms, state-specific encounter rules, and both compounded and FDA-approved cash-pay options.

The main comparison issue is pricing structure. Consumers should compare the actual $597 or $897 12-week charge—or the full amount due for another selected plan—rather than relying only on a monthly average. They should also confirm the actual dispensing pharmacy, cancellation timing, laboratory costs, and any six-month satisfaction-policy conditions before enrolling.

Medical disclaimer: This page is for consumer education and provider comparison only. It does not provide medical advice, diagnose conditions, or determine eligibility for prescription medication. Eligibility and treatment decisions are made by licensed healthcare professionals. Compounded medications are not FDA-approved finished drug products; discuss risks, benefits, alternatives, and appropriate treatment with a licensed clinician.